Company Filing History:
1 out of 4 
1 out of 1,247 
Years Active: 2025
Title: Hojin Yeom: Innovator in Antibody Conjugation Technology
Introduction
Hojin Yeom is a notable inventor based in Incheon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of compounds that enhance antibody functionality.
Latest Patents
Hojin Yeom holds a patent for a "Compound comprising Fc-binding unit, and conjugate prepared using same." This innovative compound is designed to transfer a group of interest to an antibody in a position-specific manner. The patent outlines methods for preparing an antibody conjugate that incorporates a group of interest, such as a reactive group, utilizing the Fc binding unit.
Career Highlights
Throughout his career, Hojin Yeom has worked with several prominent organizations. He has been associated with Abtis Co., Ltd., where he contributed to advancements in antibody technologies. Additionally, he has been involved with Sungkyunkwan University, furthering research and development in his field.
Collaborations
Hojin Yeom has collaborated with Yeong Soo Oh, enhancing the scope of his research and innovations.
Conclusion
Hojin Yeom's work in antibody conjugation technology represents a significant advancement in biotechnology. His innovative approaches and patented compounds have the potential to impact various applications in medical and research fields.